[HTML][HTML] Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980
Background After a peak in the late 1980s, cancer mortality in Europe has declined by∼
10% in both sexes up to the early 2000s. We provide an up-to-date picture of patterns and …
10% in both sexes up to the early 2000s. We provide an up-to-date picture of patterns and …
Current prevalence of major cancer risk factors and screening test use in the United States: disparities by education and race/ethnicity
Overall cancer death rates in the United States have declined since 1990. The decline could
be accelerated by eliminating socioeconomic and racial disparities in major risk factors and …
be accelerated by eliminating socioeconomic and racial disparities in major risk factors and …
Annual report to the nation on the status of cancer, 1975–2014, featuring survival
Abstract Background The American Cancer Society (ACS), the Centers for Disease Control
and Prevention (CDC), the National Cancer Institute (NCI), and the North American …
and Prevention (CDC), the National Cancer Institute (NCI), and the North American …
[HTML][HTML] European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
Background We predicted cancer mortality statistics for 2021 for the European Union (EU)
and its five most populous countries plus the UK. We also focused on pancreatic cancer and …
and its five most populous countries plus the UK. We also focused on pancreatic cancer and …
Early detection of prostate cancer: AUA Guideline
HB Carter, PC Albertsen, MJ Barry, R Etzioni… - The Journal of …, 2013 - auajournals.org
Purpose: The guideline purpose is to provide the urologist with a framework for the early
detection of prostate cancer in asymptomatic average risk men. Materials and Methods: A …
detection of prostate cancer in asymptomatic average risk men. Materials and Methods: A …
Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
H Grönberg, J Adolfsson, M Aly, T Nordström… - The lancet …, 2015 - thelancet.com
Background The prostate-specific antigen (PSA) test is used to screen for prostate cancer
but has a high false-positive rate that translates into unnecessary prostate biopsies and …
but has a high false-positive rate that translates into unnecessary prostate biopsies and …
American Cancer Society prostate cancer survivorship care guidelines
TA Skolarus, AMD Wolf, NL Erb… - CA: a cancer journal …, 2014 - Wiley Online Library
Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in
number and represent 1 in 5 of all cancer survivors in the United States. While guidelines …
number and represent 1 in 5 of all cancer survivors in the United States. While guidelines …
Long-term survival of participants in the prostate cancer prevention trial
IM Thompson Jr, PJ Goodman… - … England Journal of …, 2013 - Mass Medical Soc
Background In the Prostate Cancer Prevention Trial (PCPT), finasteride significantly reduced
the risk of prostate cancer but was associated with an increased risk of high-grade disease …
the risk of prostate cancer but was associated with an increased risk of high-grade disease …
Prostate cancer screening
WJ Catalona - Medical Clinics, 2018 - medical.theclinics.com
The US Preventive Services Task Force (USPSTF) has dropped its opposition to routine
prostate cancer (PCa) screening in favor of a shared decision-making process between men …
prostate cancer (PCa) screening in favor of a shared decision-making process between men …
Prostate cancer survival in the United States by race and stage (2001‐2009): findings from the CONCORD‐2 study
CB Steele, J Li, B Huang, HK Weir - Cancer, 2017 - Wiley Online Library
BACKGROUND The 5‐year relative survival for prostate cancers diagnosed between 1990
and 1994 in the United States was very high (92%); however, survival in black males was …
and 1994 in the United States was very high (92%); however, survival in black males was …